Christopher B Ehrlich's Net Worth

-$33.7 Million

Who is Christopher B Ehrlich?

Christopher B Ehrlich does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TESARO, Inc., ANESIVA, INC., INTRALASE CORP, MYOGEN INC, EnteroMedics Inc, Trius Therapeutics Inc, PHOENIX BIOTECH ACQUISITION CORP., eFFECTOR Therapeutics, Inc., Transcept Pharmaceuticals Inc, and BIOMIMETIC THERAPEUTICS, INC..

SEC CIK

Christopher B Ehrlich's CIK is 0001293973

Past Insider Trading and Trends

2005 was Christopher B Ehrlich's most active year for acquiring shares with 17 total transactions. Christopher B Ehrlich's most active month to acquire stocks was the month of May. 2004 was Christopher B Ehrlich's most active year for disposing of shares, totalling 9 transactions. Christopher B Ehrlich's most active month to dispose stocks was the month of September. 2009 saw Christopher B Ehrlich paying a total of $8,000,004.50 for 2,202,985 shares, this is the most they've acquired in one year. In 2012 Christopher B Ehrlich cashed out on 9,195,402 shares for a total of $0.00, their largest year based on trade value.